Table 2.
HW (n = 77) | OV (n = 82) | OB (n = 83) | P | |
---|---|---|---|---|
TC, mg/dL |
143 (32.1) |
140 (34.3) |
142 (39.8) |
0.864 |
LDL-C, mg/dL |
86 (33.5) |
85 (35.6) |
89 (40.1) |
0.800 |
HDL-C, mg/dL |
42 (13.5) |
37 (13.3)* |
35 (12.6)* |
<0.001 |
TG, mg/dL |
75 (29.7) |
87 (49.7) |
91 (45.1)* |
0.07 |
TG/HDL-C |
1.90 (0.86) |
2.69 (1.98)* |
3.07 (2.24)* |
0.001 |
TC/HDL-C |
3.67 (1.39) |
4.02 (1.72) |
4.59 (2.16)* |
0.021 |
LDL-C/HDL-C |
1.81 (0.52) |
1.90 (0.90) |
1.79 (0.71) |
0.051 |
Non HDL-C |
100.9 (33.9) |
102.6 (38.3) |
107.1 (43.2) |
0,575 |
Apo AI, mg/dL |
120.9 (18.0) |
113.7 (19.6) |
109.1 (21.2)* |
0.001 |
Apo B, mg/dL |
62.8 (10.6) |
65.2 (15.8) |
65.2 (17.5) |
0.533 |
Apo B/Apo AI |
0.53 (0.12) |
0.60 (0.15) |
0.61 (0.16)* |
0.003 |
LDL-C/ApoB |
1.38 (0.4) |
1.33 (0.48) |
1.37 (0.53) |
0.810 |
HDL-C/ApoA |
0.35 (0.09) |
0.33 (0.12) |
0.32 (0.10) |
0.122 |
LDL (−), mg/mL |
8.9 (5) |
10.8 (4.9) |
10.5 (5.2) * |
0.042 |
Anti LDL(−), mg/mL |
8.5 (2.6) |
7.5 (2.7)* |
7.2 (3.0)* |
0.010 |
HDL size, nm |
10.8 (2.7) |
10.8 (2.3) |
10.9 (3.2) |
0.638 |
Glucose, mg/dL |
79.3 (12.8) |
78.0 (12.5) |
82.0 (13.2) |
0.130 |
Insulin, uU/mL |
15.3 (7.1) |
19.8 (8.2)* |
25.9 (14.5)*;** |
<0.001 |
HOMA-IR | 3.0 (1.5) | 3.9 (2.0)* | 5.3 (3.1)*;** | <0.001 |
HW, healthy weight; OV, overweight; OB, obese; BMI, Body Mass Index; WC, waist circumference, HOMA-IR, homeostasis model assessment of insulin resistance; TC, total cholesterol; LDL, low density lipoprotein; HDL, high density lipoprotein.
Results were described as mean (standard deviation). *P < 0.05 vs HW group. **P < 0.05 vs OV group.